These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparative study of pentoxifylline vs antiaggregants in patients with transient ischaemic attacks. Herskovits E; Famulari A; Tamaroff L; Gonzalez AM; Vzquez A; Dominguez R; Fraiman H; Vila J; Benjamin V; Matera V Acta Neurol Scand Suppl; 1989; 127():31-5. PubMed ID: 2631519 [TBL] [Abstract][Full Text] [Related]
3. A randomized clinical trial of pentoxifylline and antiaggregants in recent transient ischemic attacks (TIA). A one year follow-up. Herskovits E; Vazquez A; Famulari A; Tamaroff L; Fraiman H; Gonzáles AM; Smud R; Vila J; Matera V Ric Clin Lab; 1981; 11 Suppl 1():257-64. PubMed ID: 6765140 [TBL] [Abstract][Full Text] [Related]
4. Randomised trial of pentoxifylline versus acetylsalicylic acid plus dipyridamole in preventing transient ischaemic attacks. Herskovits E; Vazquez A; Famulari A; Smud R; Tamaroff L; Fraiman H; Gonzalez AM; Vila J; Matera V Lancet; 1981 May; 1(8227):966-8. PubMed ID: 6112386 [TBL] [Abstract][Full Text] [Related]
5. Prevention of post-operative thrombosis in peripheral arteriopathies. Pentoxifylline vs. conventional antiaggregants: a six-month randomized follow-up study. Lucas MA Angiology; 1984 Jul; 35(7):443-50. PubMed ID: 6465619 [TBL] [Abstract][Full Text] [Related]
6. Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial. Mok CK; Boey J; Wang R; Chan TK; Cheung KL; Lee PK; Chow J; Ng RP; Tse TF Circulation; 1985 Nov; 72(5):1059-63. PubMed ID: 3899404 [TBL] [Abstract][Full Text] [Related]
7. Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials. Leonardi-Bee J; Bath PM; Bousser MG; Davalos A; Diener HC; Guiraud-Chaumeil B; Sivenius J; Yatsu F; Dewey ME; Stroke; 2005 Jan; 36(1):162-8. PubMed ID: 15569877 [TBL] [Abstract][Full Text] [Related]
8. Ticlopidine-pentoxifylline combination in the treatment of atherosclerosis and the prevention of cerebrovascular accidents. Apollonio A; Castignani P; Magrini L; Angeletti R J Int Med Res; 1989; 17(1):28-35. PubMed ID: 2651175 [TBL] [Abstract][Full Text] [Related]
9. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial. Serebruany VL; Malinin AI; Pokov AN; Hanley DF Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263 [TBL] [Abstract][Full Text] [Related]
10. The efficacy and safety of aspirin plus dipyridamole versus aspirin in secondary prevention following TIA or stroke: a meta-analysis of randomized controlled trials. Li X; Zhou G; Zhou X; Zhou S J Neurol Sci; 2013 Sep; 332(1-2):92-6. PubMed ID: 23871093 [TBL] [Abstract][Full Text] [Related]
11. [Pentoxifylline and arterial hypertension in diabetes mellitus: long-term results in randomized groups]. Solerte SB; Adamo S; Viola C; Zambianchi E; Ferrari E Ric Clin Lab; 1985; 15 Suppl 1():515-26. PubMed ID: 4035232 [TBL] [Abstract][Full Text] [Related]
12. [Randomized clinical study of the efficacy of buflomedil in the prevention of recurrence of cerebral ischemia in comparison with anti-platelet aggregation agents]. De Martiis M; Parenzi A; Barlattani A; De Martiis A Clin Ter; 1986 Mar; 116(5):367-71. PubMed ID: 3519061 [No Abstract] [Full Text] [Related]
13. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines. Hankey GJ Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741 [TBL] [Abstract][Full Text] [Related]
14. [Prevention of recurrences of cerebral ischemic vascular accidents by platelet antiaggregants. Results of a 3-year controlled therapeutic trial]. Guiraud-Chaumeil B; Rascol A; David J; Boneu B; Clanet M; Bierme R Rev Neurol (Paris); 1982; 138(5):367-85. PubMed ID: 6815756 [No Abstract] [Full Text] [Related]
15. Dipyridamole plus aspirin versus aspirin alone in secondary prevention after TIA or stroke: a meta-analysis by risk. Halkes PH; Gray LJ; Bath PM; Diener HC; Guiraud-Chaumeil B; Yatsu FM; Algra A J Neurol Neurosurg Psychiatry; 2008 Nov; 79(11):1218-23. PubMed ID: 18535024 [TBL] [Abstract][Full Text] [Related]
16. [Guidelines recommend aspirin/dipyridamole retard in high recurrence risk. Well protected from the second stroke]. Schwab S MMW Fortschr Med; 2009 Jul; 151(30-33):60-1. PubMed ID: 19722467 [No Abstract] [Full Text] [Related]
17. Aspirin plus dipyridamole versus aspirin for prevention of vascular events after stroke or TIA: a meta-analysis. Verro P; Gorelick PB; Nguyen D Stroke; 2008 Apr; 39(4):1358-63. PubMed ID: 18323511 [TBL] [Abstract][Full Text] [Related]